Skip to main content
Log in

Therapie von Keloiden

Therapy of keloids

  • CME Weiterbildung • Zertifizierte Fortbildung
  • Published:
Der Hautarzt Aims and scope Submit manuscript

Zusammenfassung

Keloide stellen gutartige Bindegewebsproliferationen dar, die meist nach einer Verletzung, aber auch spontan bzw. nach Mikrotraumen bei prädisponierten Patienten entstehen können. Im Unterschied zu hypertrophen Narben dehnen sich Keloide über die Grenze der ursprünglichen Verletzung hinaus aus und neigen nicht zur spontanen Rückbildung. Keloide sind häufig assoziiert mit Juckreiz und können durch ihr expansives und fibröses Wachstum nicht nur zu Funktionseinschränkung, Spannungsgefühl und Schmerzen führen, sondern auch zu kosmetischen und psychischen Problemen. Keloide sind eine therapeutische Herausforderung für den Dermatologen, da zwar zahlreiche Therapieoptionen zur Verfügung stehen, jedoch bis heute keine sicher wirksame, nebenwirkungsarme Therapie existiert. Im Folgenden wird auf die einzelnen Methoden der Keloidtherapie mit ihren Vor- und Nachteilen genauer eingegangen.

Abstract

Keloids are benign fibrous growths that appear after surgery, trauma or “spontaneously” as a consequence of microtrauma in predisposed patients. Keloids are distinguished from hypertrophic scars in that keloids extend beyond the margins of the original wound and do not tend to regress spontaneously. Keloids are often associated with pruritus and pain and can lead to functional and cosmetic deformities. Keloids are a therapeutic challenge for the dermatologist; although multiple treatment options are available, a reliably effective approach with few side effects remains elusive. High quality research in evaluating keloid therapy is also lacking. This article summarizes the methods used for the treatment of keloids showing their advantages and disadvantages.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2
Abb. 3
Abb. 4
Abb. 5
Abb. 6
Abb. 7
Abb. 8

Literatur

  1. Alibert JLM (1816) Note sur la keloide. J Universel Sci Medicales 2: 207–216

    Google Scholar 

  2. Marneros AG, Krieg T (2004) Keloids – clinical diagnosis, pathogenesis, and treatment options. JDDG 2: 905–913

    Article  PubMed  Google Scholar 

  3. Al-Attar A, Mess S, Thomassen JM et al. (2006) Keloid pathogenesis and treatment. Plast Reconstr Surg 117: 286–300

    Article  PubMed  Google Scholar 

  4. Younai S, Nichter LS, Wellisz T et al. (1994) Modulation of collagen synthesis by transforming growth factor-β in keloid and hypertrophic scar fibroblasts. Ann Plast Surg 33: 148–151

    Article  PubMed  Google Scholar 

  5. Slemp AE, Kirschner RE (2006) Keloids and scars: a review of keloids and scars, their pathogenesis, risk factors, and management. Curr Opin Pediatr 18: 396–402

    Article  PubMed  Google Scholar 

  6. Mustoe TA, Cooter RD, Gold MH et al (2002) International clinical recommendations on scar management. Plast Reconstr Surg 110: 560–571

    Article  PubMed  Google Scholar 

  7. Koller J, Sebastian G (2004) Therapie pathologischer Narben (hypertrophe Narben und Keloide). Leitlinie. JDDG 2: 308–312

    Article  PubMed  Google Scholar 

  8. Durani P, Bayat A (2007) Levels of evidence for the treatment of keloid disease. J Plast Reconstr Aesthet Surg (online first, in press)

  9. Gold MH, Foster TD, Adair MA et al. (2001) Prevention of hypertrophic scars and keloids by the prophylactic use of topical silicone gel sheets following a surgical procedure in an office setting. Dermatol Surg 27: 641–644

    Article  PubMed  Google Scholar 

  10. Niessen FB, Spauwen PH, Robinson PH et al. (1998) The use of silicone occlusive sheeting (Sil-K) and silicone occlusive gel (Epiderm) in the prevention of hypertrophic scar formation. Plast Reconstr Surg 102: 1962–1972

    Article  PubMed  Google Scholar 

  11. O’Brien L, Pandit A (2006) Silicone gel sheeting for preventing and treating hypertrophic and keloid scars (Review). Cochrane Database of systematic reviews Issue 1

  12. English RS, Shenefelt PD (1999) Keloids and hypertrophic scars. Dermatol Surg 25: 631–638

    Article  PubMed  Google Scholar 

  13. Bouzari N, Davis SC, Nouri K (2007) Laser treatment of keloids and hypertrophic scars. Int J Dermatol 46: 80–88

    Article  PubMed  Google Scholar 

  14. Alster TS, Williams CM (1995) Treatment of keloid sternotomy scars with 585 nm flashlamp-pumped pulsed-dye laser. Lancet 345:11998–1200

    Article  Google Scholar 

  15. Paquet P, Hermans JF, Pierard GE (2001) Effect of the 585 nm flashalmp-pumped pulsed dye laser for the treatment of keloids. Dermatol Surg 27: 171–174

    Article  PubMed  Google Scholar 

  16. De Lorenzi F, Tielemans HJP, van der Hulst RRWJ et al. (2007) Is the treatment of keloid scars still a challenge in 2006? Ann Plast Surg 58: 186–192

    Article  Google Scholar 

  17. Gupta S, Kalra A (2002) Efficacy and safety of intralesional 5-fluorouracil in the treatment of keloids. Dermatol 204: 130–132

    Article  Google Scholar 

  18. Nanda S, Reddy BS (2004) Intralesional 5-fluorouracil as a treatment modality of keloids. Dermatol Surg 30: 54–56

    Article  PubMed  Google Scholar 

  19. Robles DT, Berg D (2007) Abnormal wound healing: keloids. Clin Dermatol 25: 26–32

    Article  PubMed  Google Scholar 

  20. España A, Solano T, Quintanilla E (2001) Bleomycin in the treatment of keloids and hypertrophic scars by multiple needle punctures. Dermatol Surg 27: 23–27

    Article  PubMed  Google Scholar 

  21. Saray Y, Gulec AT (2005) Treatment of keloids and hypertrophic scars with dermojet injections of bleomycin: a preliminary study. Int J Dermatol 44: 777–784

    Article  PubMed  Google Scholar 

  22. Berman B et al. (1997) Recurrence rates of excided keloids treated with postoperative triamcinolone acetone injections or interferon alfa-2b injections. J Am Acad Dermatol 37: 755–757

    Article  PubMed  Google Scholar 

  23. Berman B, Kaufman J (2002) Pilot study of the effect of postoperative imiquimod 5% cream on the recurrence rate of excised keloids. J Am Acad Dermatol 47: S209–S211

    Article  PubMed  Google Scholar 

  24. Malhotra AK, Gupta S, Khaitan BK, Sharma VK (2007) Imiquimod 5% cream for the prevention of recurrence after excision of presternal keloids. Dermatol 215: 63–65

    Article  Google Scholar 

  25. Hackert I, Aschoff R, Sebastian G (2003) Keloide und ihre Therapie. Hautarzt 54: 1003–1017

    Article  PubMed  Google Scholar 

Download references

Interessenkonflikt

Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S. Karrer.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Karrer, S. Therapie von Keloiden. Hautarzt 58, 979–990 (2007). https://doi.org/10.1007/s00105-007-1406-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00105-007-1406-x

Schlüsselwörter

Keywords

Navigation